Multiple sclerosis

Guidelines (8)
Drug Sections (1)

Multiple sclerosis in the News

First treatment for primary progressive MS launched

First treatment for primary progressive MS launched

Ocrevus (ocrelizumab) is the first disease-modifying...

First oral short-course treatment for MS

First oral short-course treatment for MS

Mavenclad (cladribine) is licensed for the treatment...

New MS treatment accepted by NICE

New MS treatment accepted by NICE

Eligible patients with multiple sclerosis (MS) must...

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more